CEO and co-founder
Criocore
Carlos Ezio is the co-founder and CEO of Criocore, a venture-backed spin-out developing cryobioprinted in vitro models for drug discovery. He spent over six years at Harvard Medical School and Brigham and Women’s Hospital, at the Shrike Zhang Lab where he built and translated advanced bioprinting platforms. Carlos is an MIT Technology Review Innovators 35 Under 35 honoree and the author of 30+ peer-reviewed publications with more than 1,750 citations, an h-index: 18, and has delivered 30+ invited lectures and presentations. He has participated in MIT’s Blueprint and MassVentures’ Founder School and served as a Founder in Residence at Antler.
Disclosure information not submitted.
Wednesday, April 15, 2026
11:40 AM - 12:10 PM East Coast USA Time